Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

Folate receptor 1 inhibitor

DRUG CLASS:

Folate receptor 1 inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

FOLR1 overexpression	Ovarian Cancer	FOLR1 overexpression	Ovarian Cancer	CT900 Sensitive: C3 – Early Trials CT900 Sensitive : C3	CT900 Sensitive: C3 – Early Trials CT900 Sensitive : C3
FOLR1 positive	Ovarian Cancer	FOLR1 positive	Ovarian Cancer	CBP-1008 Sensitive: C3 – Early Trials CBP-1008 Sensitive : C3	CBP-1008 Sensitive: C3 – Early Trials CBP-1008 Sensitive : C3
TRPV6 positive	Ovarian Cancer	TRPV6 positive	Ovarian Cancer	CBP-1008 Sensitive: C3 – Early Trials CBP-1008 Sensitive : C3	CBP-1008 Sensitive: C3 – Early Trials CBP-1008 Sensitive : C3
FOLR1 positive + TRPV6 positive	Ovarian Cancer	FOLR1 positive + TRPV6 positive	Ovarian Cancer	CBP-1008 Sensitive: C3 – Early Trials CBP-1008 Sensitive : C3	CBP-1008 Sensitive: C3 – Early Trials CBP-1008 Sensitive : C3
FOLR1 expression	Ovarian Cancer	FOLR1 expression	Ovarian Cancer	CT900 Sensitive: C3 – Early Trials CT900 Sensitive : C3	CT900 Sensitive: C3 – Early Trials CT900 Sensitive : C3